NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 71 filers reported holding NEURODERM LTD in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,018,000 | +72.9% | 77,578 | +32.9% | 0.00% | – |
| Q2 2017 | $1,746,000 | +39.2% | 58,378 | +23.6% | 0.00% | – |
| Q1 2017 | $1,254,000 | -13.6% | 47,215 | -28.4% | 0.00% | – |
| Q4 2016 | $1,452,000 | +148.6% | 65,939 | +108.6% | 0.00% | – |
| Q3 2016 | $584,000 | +82.5% | 31,609 | +60.4% | 0.00% | – |
| Q2 2016 | $320,000 | – | 19,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
| ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
| Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
| Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
| NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
| SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
| Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
| Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
| RA Capital Management | 144,671 | $2,467,000 | 0.24% |